• 9936 Citations
  • 53 h-Index
19992019
If you made any changes in Pure these will be visible here soon.

Research Output 1999 2019

2019
Hungary
Crohn Disease
Databases
Biosimilar Pharmaceuticals
Pharmaceutical Preparations
6 Citations (Scopus)

Biosimilars for the management of inflammatory bowel diseases: Economic considerations

Gulácsi, L., Pentek, M., Rencz, F., Brodszky, V., Baji, P., Vegh, Z., Gecse, K. B., Danese, S., Peyrin-Biroulet, L. & Lakatos, P., jan. 1 2019, In : Current medicinal chemistry. 26, 2, p. 259-269 11 p.

Research output: Article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Economics
Budgets
Health
2 Citations (Scopus)

Biosimilars in IBD: Will it benefit to patients, physicians or the health care system?

Gonczi, L., Ilias, A., Kurti, Z. & Lakatos, P., jan. 1 2019, In : Current pharmaceutical design. 25, 1, p. 13-18 6 p.

Research output: Article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Delivery of Health Care
Physicians
Safety

Can We Say No to the 'Nocebo Effect' in Inflammatory Bowel Diseases?

Gonczi, L. & Lakatos, P., szept. 19 2019, In : Journal of Crohn's & colitis. 13, 9, p. 1095-1096 2 p.

Research output: Article

Nocebo Effect
Inflammatory Bowel Diseases
1 Citation (Scopus)

Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review

Restellini, S., Chao, C. Y., Martel, M., Barkun, A., Kherad, O., Seidman, E., Wild, G., Bitton, A., Afif, W., Bessissow, T. & Lakatos, P., jún. 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1265-1275.e8

Research output: Review article

Open Access
Ulcerative Colitis
Hemorrhage
Colitis
Endoscopy
Observational Studies
Inflammatory Bowel Diseases
Population
Ulcerative Colitis
Crohn Disease
Mesalamine

Disease monitoring strategies in inflammatory bowel diseases: What do we mean by "tight control"?

Gonczi, L., Bessissow, T. & Lakatos, P. L., nov. 7 2019, In : World journal of gastroenterology. 25, 41, p. 6172-6189 18 p.

Research output: Review article

Open Access
Inflammatory Bowel Diseases
Therapeutics
Biomarkers
Leukocyte L1 Antigen Complex
Secondary Prevention

Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape

LeBlanc, J. F., Wiseman, D., Lakatos, P. & Bessissow, T., aug. 14 2019, In : World journal of gastroenterology. 25, 30, p. 4158-4171 14 p.

Research output: Review article

Open Access
Inflammatory Bowel Diseases
Biological Factors
Biological Products
Crohn Disease
Sample Size

Endoscopic surveillance strategies for dysplasia in ulcerative colitis

Verdon, C., Aruljothy, A., Lakatos, P. & Bessissow, T., jan. 1 2019, In : Frontline Gastroenterology.

Research output: Review article

Ulcerative Colitis
Colorectal Neoplasms
Biopsy
Sclerosing Cholangitis
Population
1 Citation (Scopus)

Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic

Reinglas, J., Restellini, S., Gonczi, L., Kurti, Z., Verdon, C., Nene, S., Kohen, R., Afif, W., Bessissow, T., Wild, G., Seidman, E., Bitton, A. & Lakatos, P., márc. 1 2019, In : Digestive and Liver Disease. 51, 3, p. 340-345 6 p.

Research output: Article

Quality of Health Care
Inflammatory Bowel Diseases
Referral and Consultation
Leukocyte L1 Antigen Complex
Drug Monitoring
1 Citation (Scopus)

Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study

Côté-Daigneault, J., Bessissow, T., Nicolae, M. V., Nie, R., Bitton, A., Lakatos, P. & Brassard, P., ápr. 11 2019, In : Inflammatory bowel diseases. 25, 5, p. 914-918 5 p.

Research output: Article

Herpes Zoster
Inflammatory Bowel Diseases
Incidence
Population
Quebec

High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, while Rates of Dysplasia are Low before the Suggested Onset of Surveillance

Singh, K., Al Khoury, A., Kurti, Z., Gonczi, L., Reinglas, J., Verdon, C., Kohen, R., Bessissow, T., Afif, W., Wild, G., Seidman, E., Bitton, A. & Lakatos, P., szept. 27 2019, In : Journal of Crohn's and Colitis. 13, 10, p. 1343-1350 8 p.

Research output: Article

Open Access
Ulcerative Colitis
Inflammatory Bowel Diseases
Crohn Disease
Colorectal Neoplasms
Guidelines
3 Citations (Scopus)

High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival

Chao, C. Y., Al Khoury, A., Aruljothy, A., Restellini, S., Wyse, J., Afif, W., Bitton, A., Lakatos, P. & Bessissow, T., febr. 15 2019, In : Digestive Diseases and Sciences. 64, 2, p. 518-523 6 p.

Research output: Article

Colectomy
Ulcerative Colitis
Survival
Therapeutics
Infliximab
Social Adjustment
Arthralgia
Tertiary Care Centers
Pharmaceutical Preparations
Safety
1 Citation (Scopus)
Open Access
Self Efficacy
Inflammatory Bowel Diseases
Physicians
Ulcerative Colitis
Crohn Disease
12 Citations (Scopus)

Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: An Epi-IBD study

Burisch, J., Kiudelis, G., Kupcinskas, L., Kievit, H. A. L., Andersen, K. W., Andersen, V., Salupere, R., Pedersen, N., Kjeldsen, J., D'Incà, R., Valpiani, D., Schwartz, D., Odes, S., Olsen, J., Nielsen, K. R., Vegh, Z., Lakatos, P., Toca, A., Turcan, S., Katsanos, K. H. & 26 others, Christodoulou, D. K., Fumery, M., Gower-Rousseau, C., Zammit, S. C., Ellul, P., Eriksson, C., Halfvarson, J., Magro, F. J., Duricova, D., Bortlik, M., Fernandez, A., Hernández, V., Myers, S., Sebastian, S., Oksanen, P., Collin, P., Goldis, A., Misra, R., Arebi, N., Kaimakliotis, I. P., Nikuina, I., Belousova, E., Brinar, M., Cukovic-Cavka, S., Langholz, E. & Munkholm, P., márc. 1 2019, In : Gut. 68, 3, p. 423-433 11 p.

Research output: Article

Crohn Disease
Population
Immunologic Factors
Eastern Europe
Biological Therapy
9 Citations (Scopus)

Natural Disease Course of Ulcerative Colitis during the First Five Years of Follow-up in a European Population-based Inception Cohort - An Epi-IBD Study

Burisch, J., Katsanos, K. H., Christodoulou, D. K., Barros, L., Magro, F., Pedersen, N., Kjeldsen, J., Vegh, Z., Lakatos, P., Eriksson, C., Halfvarson, J., Fumery, M., Gower-Rousseau, C., Brinar, M., Čuković-Čavka, S., Nikulina, I., Belousova, E., Myers, S., Sebastian, S., Kiudelis, G. & 27 others, Kupcinskas, L., Schwartz, D., Odes, S., Kaimakliotis, I. P., Valpiani, D., D'Incà, R., Salupere, R., Chetcuti Zammit, S., Ellul, P., Duricova, D., Bortlik, M., Goldis, A., Kievit, H. A. L., Toca, A., Turcan, S., Midjord, J., Nielsen, K. R., Andersen, K. W., Andersen, V., Misra, R., Arebi, N., Oksanen, P., Collin, P., De Castro, L., Hernandez, V., Langholz, E. & Munkholm, P., febr. 1 2019, In : Journal of Crohn's and Colitis. 13, 2, p. 198-208 11 p.

Research output: Article

Ulcerative Colitis
Population
Immunologic Factors
Biological Therapy
Colitis
4 Citations (Scopus)

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

Ilias, A., Szanto, K., Gonczi, L., Kurti, Z., Golovics, P. A., Farkas, K., Schafer, E., Szepes, Z., Szalay, B., Vincze, A., Szamosi, T., Molnar, T. & Lakatos, P. L., nov. 2019, In : Clinical Gastroenterology and Hepatology. 17, 12, p. 2506-2513.e2

Research output: Article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis
Therapeutics

Patient and general population values for luminal and perianal fistulising Crohn’s disease health states

Rencz, F., Stalmeier, P. F. M., Péntek, M., Brodszky, V., Ruzsa, G., Gönczi, L., Palatka, K., Herszényi, L., Schäfer, E., Banai, J., Rutka, M., Gulácsi, L. & Lakatos, P., jún. 1 2019, In : European Journal of Health Economics. 20, p. 91-100 10 p.

Research output: Article

Open Access
Crohn Disease
Health
Fistula
Population
Quality of Life
2 Citations (Scopus)

Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre

Gonczi, L., Kurti, Z., Verdon, C., Reinglas, J., Kohen, R., Morin, I., Chavez, K., Bessissow, T., Afif, W., Wild, G., Seidman, E., Bitton, A. & Lakatos, P., szept. 19 2019, In : Journal of Crohn's & colitis. 13, 9, p. 1138-1147 10 p.

Research output: Article

Open Access
Quality of Health Care
Inflammatory Bowel Diseases
Quality of Life
Prospective Studies
Phenotype
Crohn Disease

Reply to Letter on: Â € Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis'

Balram, B., Battat, R., Al-Khoury, A., D'Aoust, J., Afif, W., Bitton, A., Lakatos, P. & Bessissow, T., márc. 30 2019, In : Journal of Crohn's and Colitis. 13, 4, p. 536-537 2 p.

Research output: Letter

Clostridium Infections
Clostridium difficile
Inflammatory Bowel Diseases
Meta-Analysis
5 Citations (Scopus)

Risk Factors Associated with Clostridium difficile infection in inflammatory bowel disease: A systematic review and meta-analysis

Balram, B., Battat, R., Al-Khoury, A., D’Aoust, J., Afif, W., Bitton, A., Lakatos, P. & Bessissow, T., jan. 1 2019, In : Journal of Crohn's and Colitis. 13, 1, p. 27-38 12 p.

Research output: Article

Clostridium Infections
Clostridium difficile
Inflammatory Bowel Diseases
Meta-Analysis
Odds Ratio

Risk of Malignant Cancers in Inflammatory Bowel Disease

Loo, S. Y., Vutcovici, M., Bitton, A., Lakatos, P., Azoulay, L., Suissa, S. & Brassard, P., szept. 27 2019, In : Journal of Crohn's and Colitis. 13, 10, p. 1302-1310 9 p.

Research output: Article

Inflammatory Bowel Diseases
Confidence Intervals
Quebec
Incidence
Odds Ratio
10 Citations (Scopus)

Screening for nonalcoholic fatty liver disease in inflammatory bowel diseases: A cohort study using transient elastography

Saroli Palumbo, C., Restellini, S., Chao, C. Y., Aruljothy, A., Lemieux, C., Wild, G., Afif, W., Lakatos, P., Bitton, A., Cocciolillo, S., Ghali, P., Bessissow, T. & Sebastiani, G., jan. 1 2019, In : Inflammatory bowel diseases. 25, 1, p. 124-133 10 p.

Research output: Article

Elasticity Imaging Techniques
Inflammatory Bowel Diseases
Cohort Studies
Liver Cirrhosis
Odds Ratio
2 Citations (Scopus)

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives

Bitton, A., Vutcovici, M., Lytvyak, E., Kachan, N., Bressler, B., Jones, J., Lakatos, P., Sewitch, M., El-Matary, W., Melmed, G. & Nguyen, G., jan. 10 2019, In : Inflammatory bowel diseases. 25, 2, p. 403-409 7 p.

Research output: Article

Inflammatory Bowel Diseases
Physicians
Workflow
Quality of Health Care
Risk Management
3 Citations (Scopus)

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development

King, J. A., Underwood, F. E., Panaccione, N., Quan, J., Windsor, J. W., Kotze, P. G., Ng, S. C., Ghosh, S., Lakatos, P., Jess, T., Panaccione, R., Seow, C. H., Ben-Horin, S., Burisch, J., Colombel, J. F., Loftus, E. V., Gearry, R., Halfvarson, J. & Kaplan, G. G., ápr. 1 2019, In : The Lancet Gastroenterology and Hepatology. 4, 4, p. 287-295 9 p.

Research output: Article

Inflammatory Bowel Diseases
Developed Countries
Hospitalization
Population
Organisation for Economic Co-Operation and Development
2 Citations (Scopus)

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

Danese, S., Allez, M., Van Bodegraven, A. A., Dotan, I., Gisbert, J. P., Hart, A., Lakatos, P., Magro, F., Peyrin-Biroulet, L., Schreiber, S., Tarabar, D., Vavricka, S., Halfvarson, J. & Vermeire, S., ápr. 1 2019, In : Digestive Diseases. 37, 4, p. 266-283 18 p.

Research output: Article

Open Access
Ulcerative Colitis
Consensus
Group Processes
Inflammatory Bowel Diseases
PubMed

Ver(s)ifying the Efficacy of Vedolizumab Therapy on Mucosal Healing in Patients With Crohn's Disease

Gonczi, L., Bessissow, T. & Lakatos, P., okt. 1 2019, In : Gastroenterology. 157, 4, p. 925-927 3 p.

Research output: Editorial

Crohn Disease
Therapeutics
vedolizumab
2018
12 Citations (Scopus)

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

Goncalves, J., Santos, M., Acurcio, R., Iria, I., Gouveia, L., Matos Brito, P., Catarina Cunha-Santos, A., Barbas, A., Galvão, J., Barbosa, I., Aires da Silva, F., Alcobia, A., Cavaco, M., Cardoso, M., Delgado Alves, J., Carey, J. J., Dörner, T., Eurico Fonseca, J., Palmela, C., Torres, J. & 12 others, Lima Vieira, C., Trabuco, D., Fiorino, G., Strik, A., Yavzori, M., Rosa, I., Correia, L., Magro, F., D'Haens, G., Ben-Horin, S., Lakatos, P. & Danese, S., szept. 1 2018, In : Alimentary Pharmacology and Therapeutics. 48, 5, p. 507-522 16 p.

Research output: Article

Inflammatory Bowel Diseases
Epitopes
Serum
Anti-Idiotypic Antibodies
CT-P13

Biosimilars in ulcerative colitis: When and for who?

Ilias, A., Gonczi, L., Kurti, Z. & Lakatos, P., febr. 1 2018, In : Best Practice and Research: Clinical Gastroenterology. 32-33, p. 35-42 8 p.

Research output: Review article

Biosimilar Pharmaceuticals
Ulcerative Colitis
Inflammatory Bowel Diseases
Safety

Can we predict disease course with clinical factors?

Vegh, Z., Kurti, Z., Golovics, P. A. & Lakatos, P., jan. 1 2018, In : Current drug targets. 19, 7, p. 791-797 7 p.

Research output: Review article

Ulcerative Colitis
Crohn Disease
Inflammatory Bowel Diseases
Phenotype
Biological Therapy
2 Citations (Scopus)

Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease

Benmassaoud, A., Al-Taweel, T., Sasson, M. S., Moza, D., Strohl, M., Kopylov, U., Paradis-Surprenant, L., Almaimani, M., Bitton, A., Afif, W., Lakatos, P. & Bessissow, T., máj. 1 2018, In : Digestive Diseases and Sciences. 63, 5, p. 1302-1310 9 p.

Research output: Article

Biological Products
Crohn Disease
Adrenal Cortex Hormones
Infliximab
Adalimumab
7 Citations (Scopus)

Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

Baji, P., Gulácsi, L., Brodszky, V., Végh, Z., Danese, S., Irving, P. M., Peyrin-Biroulet, L., Schreiber, S., Rencz, F., Lakatos, P. & Péntek, M., márc. 1 2018, In : United European Gastroenterology Journal. 6, 2, p. 310-321 12 p.

Research output: Article

Biosimilar Pharmaceuticals
Crohn Disease
Cost-Benefit Analysis
Quality-Adjusted Life Years
Costs and Cost Analysis
30 Citations (Scopus)

Development of an index to define overall disease severity in IBD

Siegel, C. A., Whitman, C. B., Spiegel, B. M. R., Feagan, B., Sands, B., Loftus, E. V., Panaccione, R., D'Haens, G., Bernstein, C. N., Gearry, R., Ng, S. C., Mantzaris, G. J., Sartor, B., Silverberg, M. S., Riddell, R., Koutroubakis, I. E., O'Morain, C., Lakatos, P., McGovern, D. P. B., Halfvarson, J. & 16 others, Reinisch, W., Rogler, G., Kruis, W., Tysk, C., Schreiber, S., Danese, S., Sandborn, W., Griffiths, A., Moum, B., Gasche, C., Pallone, F., Travis, S., Panes, J., Colombel, J. F., Hanauer, S. & Peyrin-Biroulet, L., febr. 1 2018, In : Gut. 67, 2, p. 244-254 11 p.

Research output: Article

Crohn Disease
Inflammatory Bowel Diseases
Biological Products
C-Reactive Protein
Abscess
49 Citations (Scopus)

ECCO-ESCP consensus on surgery for Crohn's disease

on behalf of the European Crohn's and Colitis Organisation , jan. 1 2018, In : Journal of Crohn's and Colitis. 12, 1, p. 1-16 16 p.

Research output: Article

Open Access
Crohn Disease
Guidelines
Open Access
Biosimilar Pharmaceuticals
Epitopes
CT-P13
Infliximab
3 Citations (Scopus)

Endoscopic management of Crohn’s strictures

Bessissow, T., Reinglas, J., Aruljothy, A., Lakatos, P. & Assche, G. V., máj. 7 2018, In : World journal of gastroenterology. 24, 17, p. 1859-1867 9 p.

Research output: Review article

Open Access
Pathologic Constriction
Dilatation
Crohn Disease
Intralesional Injections
Stents
3 Citations (Scopus)

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis–results from multicenter observational cohort

Bálint, A., Rutka, M., Kolar, M., Bortlik, M., Duricova, D., Hruba, V., Lukas, M., Mitrova, K., Malickova, K., Lukas, M., Szepes, Z., Nagy, F., Palatka, K., Lovas, S., Végh, Z., Kürti, Z., Csontos, Á., Miheller, P., Nyári, T., Bor, R. & 6 others, Milassin, Á., Fábián, A., Szántó, K., Lakatos, P., Molnár, T. & Farkas, K., nov. 2 2018, In : Expert Opinion on Biological Therapy. 18, 11, p. 1181-1187 7 p.

Research output: Article

Biosimilar Pharmaceuticals
Ulcerative Colitis
Leukocyte L1 Antigen Complex
Antibodies
Azathioprine
1 Citation (Scopus)

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

Tornai, T., Tornai, D., Sipeki, N., Tornai, I., Alsulaimani, R., Fechner, K., Roggenbuck, D., Norman, G. L., Verès, G., Pár, G., Pár, A., Szalay, F., Lakatos, P., Antal-Szalmás, P. & Papp, M., dec. 1 2018, In : Scientific Reports. 8, 1, 399.

Research output: Article

Sclerosing Cholangitis
Immunity
Glycoproteins
Immunoglobulin A
Autoantibodies
3 Citations (Scopus)

Optimizing patient management in crohn’s disease in a tertiary referral center: The impact of fast-track mri on patient management and outcomes

Ilias, A., Lovasz, B. D., Gonczi, L., Kurti, Z., Vegh, Z., Sumegi, L. D., Golovics, P. A., Rudas, G. & Lakatos, P., dec. 1 2018, In : Journal of Gastrointestinal and Liver Diseases. 27, 4, p. 391-397 7 p.

Research output: Article

Open Access
Tertiary Care Centers
Crohn Disease
Magnetic Resonance Imaging
Biomarkers
Therapeutics
10 Citations (Scopus)

Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases

Reinglas, J., Gonczi, L., Kurt, Z., Bessissow, T. & Lakatos, P., aug. 28 2018, In : World journal of gastroenterology. 24, 32, p. 3567-3582 16 p.

Research output: Review article

Open Access
Inflammatory Bowel Diseases
Therapeutics
Tumor Necrosis Factor-alpha
Physiologic Monitoring
Lymphocyte Activation
3 Citations (Scopus)

Progress with infliximab biosimilars for inflammatory bowel disease

Kurti, Z., Gonczi, L. & Lakatos, P., jún. 3 2018, In : Expert Opinion on Biological Therapy. 18, 6, p. 633-640 8 p.

Research output: Review article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Biological Therapy
Safety
Expert Testimony
5 Citations (Scopus)

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies

Gonczi, L., Kurti, Z., Golovics, P. A., Lovasz, B. D., Menyhart, O., Seres, A., Sumegi, L. D., Gal, A., Ilias, A., Janos, P., Gecse, K. B., Bessisow, T., Afif, W., Bitton, A., Vegh, Z. & Lakatos, P., jan. 1 2018, In : Digestive and Liver Disease. 50, 1, p. 37-41 5 p.

Research output: Article

Quality of Health Care
Inflammatory Bowel Diseases
Tertiary Care Centers
Endoscopy
Gastroscopy
2 Citations (Scopus)

Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?

Strohl, M., Gonczi, L., Kurt, Z., Bessissow, T. & Lakatos, P., jún. 14 2018, In : World journal of gastroenterology. 24, 22, p. 2363-2372 10 p.

Research output: Review article

Open Access
Quality of Health Care
Inflammatory Bowel Diseases
Telemedicine
Disease Management
Standard of Care
19 Citations (Scopus)

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries

Shah, S. C., Khalili, H., Gower-Rousseau, C., Olen, O., Benchimol, E. I., Lynge, E., Nielsen, K. R., Brassard, P., Vutcovici, M., Bitton, A., Bernstein, C. N., Leddin, D., Tamim, H., Stefansson, T., Loftus, E. V., Moum, B., Tang, W., Ng, S. C., Gearry, R., Sincic, B. & 8 others, Bell, S., Sands, B. E., Lakatos, P., Végh, Z., Ott, C., Kaplan, G. G., Burisch, J. & Colombel, J. F., okt. 1 2018, In : Gastroenterology. 155, 4, p. 1079-1089.e3

Research output: Article

Sex Characteristics
Inflammatory Bowel Diseases
Incidence
Ulcerative Colitis
Crohn Disease
6 Citations (Scopus)

Therapeutic drug monitoring guides the management of Crohn's patients with secondary loss of response to adalimumab

Restellini, S., Chao, C. Y., Lakatos, P., Aruljothy, A., Aziz, H., Kherad, O., Bitton, A., Wild, G., Afif, W. & Bessissow, T., jan. 1 2018, In : Inflammatory bowel diseases. 24, 7, p. 1531-1538 8 p.

Research output: Article

Drug Monitoring
Serum
Adalimumab
Equidae
Immunologic Factors
1 Citation (Scopus)

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: A nationwide study based on the National Health Insurance Fund database

Kurti, Z., Ilias, A., Gonczi, L., Vegh, Z., Fadgyas-Freyler, P., Korponay, G., Golovics, P. A., Lovasz, B. D. & Lakatos, P., jan. 30 2018, In : BMC gastroenterology. 18, 1, 23.

Research output: Article

Open Access
Hungary
National Health Programs
Crohn Disease
Databases
Immunosuppressive Agents

The role of therapeutic drug monitoring for TNF inhibitors in IBD: Selected cases or everyday practice?

Gonczi, L., Vegh, Z., Kurti, Z., Ilias, A. & Lakatos, P., jan. 1 2018, Advances in Health and Disease. Nova Science Publishers, Inc., Vol. 4. p. 69-104 36 p.

Research output: Chapter

Drug Monitoring
Inflammatory Bowel Diseases
Tumor Necrosis Factor-alpha
Therapeutics
Treatment Failure
2 Citations (Scopus)

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

Rencz, F., Lakatos, P., Gulácsi, L., Brodszky, V., Kürti, Z., Lovas, S., Banai, J., Herszényi, L., Cserni, T., Molnár, T., Péntek, M. & Palatka, K., jan. 1 2018, (Accepted/In press) In : Quality of Life Research.

Research output: Article

Crohn Disease
Visual Analog Scale
Psychometrics
Fistula
Cost-Benefit Analysis